USPTO serial 98015957
PHARMALEX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 4, 2025
- Examiner
- WU, KRISTEN ZAHNOW
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with PHARMALEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Friedrichsdorf, DE
Friedrichsdorf, DE
Friedrichsdorf, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Anita B. Polott
Anita B. Polott Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWAttn: TMSUWashington, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Advertising and marketing; management of business for others; business administration; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business development services and advice in the field of drug distribution in retail and wholesale stores for advertising purposes; providing outsourced office functions services for drug approval, manufacturing, distribution, supply chain security and safety monitoring; assistance and consultancy in the field of distributing medicines for advertising purposes via retail stores and wholesale stores; business consultancy services in the fields of controlling and managing business information and implementing and managing databases; regulatory submission management, namely, assisting others in preparing and filing applications, documents, reports and records for new drugs required for drug approval by governmental regulatory authorities; advisory services in the field of regulatory submission management to assist companies with applications for pharmaceuticals, biopharmaceuticals, and medical devices; business advice and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing marketing authorization applications with governmental regulatory bodies following approval of new drugs; consultancy relating to conducting quality assurance for manufacturing for pharmaceutical companies | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of pharmaceuticals, medical devices, and biopharmaceuticals; scientific, medical and pharmaceutical research and development services; industrial analysis and research services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; research and development of new products for others; pharmaceutical drug development services; research and development of pharmaceutical preparations; scientific, medical, biotechnological, and pharmaceutical research services; biological research and analysis services for scientific and technological purposes; technological research services relating to pharmaceuticals, biopharmaceuticals, and medical devices; biological research; clinical research in the field of pharmaceuticals, medical devices, and biopharmaceuticals; providing medical research and scientific research information; provision of scientific information in the nature of scientific surveys; scientific laboratory services; medical research laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars, therapeutics; computer software development of a web application for entering and evaluating informative texts for pharmaceuticals and medical products, in particular instructions for use, package inserts, specialist information and for the provision of various documents; database services, namely, electronic storage of data in computer databases; conversion of data or documents from physical to electronic media; testing, inspection or research of pharmaceuticals and medicines; design, engineering, research, development and testing services in the field of pharmaceuticals, medical devices, and biopharmaceuticals; research in the field of gene therapy; consultancy relating to quality management services, namely, quality assurance and quality control in the field of pharmaceuticals, pharmaceutical manufacturing, medical devices, and biopharmaceuticals; research services relating to scientific work; preparation of scientific research analyses and evaluations relating to pharmaceuticals, medical devices, and biopharmaceuticals; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to scientific laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; information technology consultancy services relating to computer software design for the pharmaceutical and healthcare industries; scientific evaluation of the drugs of others to determine drug efficacy; research and development services for assessing the efficiency of pharmaceuticals; analysis and evaluation of product design for others; analysis and evaluation of product development for others; quality control testing for others; materials testing and evaluation; product safety testing; quality control and evaluation of goods of others to determine conformity with certification standards; quality testing of products for certification purposes; consulting and advice on drug safety and monitoring for product research and development purposes; consultancy services for others in the field of design, planning, implementation and project management of clinical trials, scientific pharmacovigilance research, and pharmaceutical and biotechnology product development; consultancy services in the fields of biotechnology, pharmaceutical research and development, laboratory testing of materials and pharmacogenetics; providing online nondownloadable software for collecting data related to clinical trials; providing online non-downloadable automation software for collecting data related to clinical trials; provision of pharmaceutical information regarding pharmaceutical research and development; consultancy and information services provided via the Internet relating to the research and development of pharmaceutical products; pharmaceutical drug development services in the field of drug safety | ACTIVE | — |
| 044 | Medical and veterinary services; advice in the field of preparation of prescriptions in pharmacies; providing medical advice regarding the appropriate medical information that should appear on labels of pharmaceutical products and biopharmaceutical products; providing information relating to the preparation and dispensing of medications; provision of information in the field of medicine; consultancy and information services provided via the Internet relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the preparation of pharmaceutical products by pharmacists; consultancy and information services relating to the dispensing of biopharmaceutical products; medical and pharmaceutical consultancy; medical services relating to the diagnosis and treatment of persons; medical analysis and examinations relating to the treatment of persons; medical analysis services relating to the treatment of persons; medical services; medical screening; medical diagnostic monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of illnesses; medical and medical diagnostic services and medical advice in the field of drug safety for the diagnosis and treatment of persons; providing information in the field of pharmacovigilance and adverse event reporting for the diagnosis and treatment of persons; medical laboratory analysis services relating to the diagnosis and treatment of persons | ACTIVE | — |
| 045 | Regulatory compliance auditing; regulatory compliance consulting in the field of pharmaceuticals, medical devices, and biopharmaceuticals; consultancy services in the fields of regulatory compliance and oversight in the field of pharmaceuticals, medical devices, and biopharmaceuticals; advisory services relating to regulatory compliance auditing; regulatory compliance consultancy in the field of prescription drug sampling | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks owned by PharmaLex GmbH
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named PHARMALEX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 4, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 4, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 17, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 17, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 19, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 19, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 19, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 19, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 7, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2024 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| May 20, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 10, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 10, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 10, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 20, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 30, 2023 | NWAP | NEW APPLICATION ENTERED | — |